← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2011Last known activity
Feb 15, 2018
Acquired by Roche on Feb 1, 2018
Timeline
2010s
- Jun 1, 2011
Ignyta, Inc.— Founded
- Feb 1, 2018
Roche— Acquired By
Drugs by trial phase (6 distinct, 10 trials)
Indications
Studied for
- Brain Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Colorectal Neoplasms
- Head and Neck Neoplasms
- Lymphoma, Large-Cell, Anaplastic
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neuroendocrine Tumors
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Salivary Gland Neoplasms
- Sarcoma
- Thyroid Cancer, Papillary
- Thyroid Neoplasms
Recent trials (15)
- NCT03454243Study chairEarly Phase 1Feb 15, 2018
- NCT03454243Lead sponsorEarly Phase 1Feb 15, 2018
- NCT03066661Lead sponsorN/AFeb 23, 2017
- NCT03052569Lead sponsorN/AFeb 10, 2017
- NCT02650401Lead sponsorPhase 1Dec 1, 2015
- NCT02650401Study directorPhase 1Dec 1, 2015
- NCT02568267Lead sponsorPhase 2Oct 1, 2015
- NCT02568267Study directorPhase 2Oct 1, 2015
- NCT02548390Lead sponsorPhase 1Sep 1, 2015
- NCT02097810Lead sponsorPhase 1Jun 1, 2014
- NCT02097810Study directorPhase 1Jun 1, 2014
- NCT01919398Study directorPhase 1Aug 1, 2013
- NCT01877811Lead sponsorPhase 1Jun 1, 2013
- NCT01226485Lead sponsorPhase 1Sep 1, 2010
- NCT01226485Study directorPhase 1Sep 1, 2010
Details
- Founded
- San Diego, California, US Jun 1, 2011
- Last known activity
- Feb 15, 2018